酰胺质子转移加权成像及其衍生定量指标评估胶质瘤:性能优于磁化转移率不对称性
研究纳入110例成人型弥漫性胶质瘤患者行APTw成像,比较MTRasym及衍生指标(MTRnormref、MTRRex及Lorentzian拟合指标)在IDH基因型、胶质瘤亚型及Ki-67表达中的诊断性能;所有APTw相关指标在IDH野生型中显著高于突变型(均p<0.001),Fit-MTRnormref鉴别IDH的AUC最高为0.858,与Ki-67相关系数最高为0.578,优于MTRasym。
要点
- APTw相关指标在IDH野生型胶质瘤中均显著高于IDH突变型(均p<0.001),Fit-MTRnormref的AUC最高为0.858。
- 胶质母细胞瘤的APTw相关指标均显著高于少突胶质细胞瘤(均p<0.01)和星形细胞瘤(均p<0.001)。
- Fit-MTRnormref鉴别星形细胞瘤与胶质母细胞瘤的AUC最高为0.870,Fit-MTRRex鉴别少突胶质细胞瘤与胶质母细胞瘤的AUC最高为0.867。
核心结论
- APTw相关指标可有效评估胶质瘤IDH状态、肿瘤亚型及增殖活性;Lorentzian拟合联合参考信号归一化可进一步提高诊断性能,且优于MTRasym。
研究设计与样本
- 共纳入110例成人型弥漫性胶质瘤患者行APTw成像,计算MTRasym、MTRnormref、MTRRex及基于Lorentzian拟合的Fit-amide、Fit-MTRnormref、Fit-MTRRex指标,比较IDH基因型间及三种胶质瘤亚型间差异,采用ROC分析评估并比较诊断性能,并分析各指标与Ki-67表达的相关性。
诊断标准与关键数值
- 所有APTw相关指标在IDH野生型胶质瘤中均显著高于IDH突变型(均p<0.001),Fit-MTRnormref的AUC最高为0.858。
- 所有APTw相关指标在胶质母细胞瘤中均显著高于少突胶质细胞瘤(均p<0.01)和星形细胞瘤(均p<0.001)。
- 少突胶质细胞瘤与星形细胞瘤之间所有指标均无显著差异。
- 鉴别星形细胞瘤与胶质母细胞瘤的最高AUC为Fit-MTRnormref的0.870,鉴别少突胶质细胞瘤与胶质母细胞瘤的最高AUC为Fit-MTRRex的0.867。
- Fit-MTRnormref与Ki-67表达的相关系数最高为0.578。
临床应用与阅片要点
- APTw相关指标可用于评估胶质瘤IDH状态、肿瘤亚型及增殖活性。
- Lorentzian拟合联合参考信号归一化可进一步提高诊断性能,且优于MTRasym。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Isocitrate dehydrogenase (IDH) status, glioma subtypes and tumor proliferation are important for glioma evaluation. We comprehensively compare the diagnostic performance of amide proton transfer-weighted (APTw) MRI and its related metrics in glioma diagnosis, in the context of the latest classification.
MATERIALS AND METHODS: Totally 110 patients with adult-type diffuse gliomas underwent APTw imaging. The magnetization transfer ratio asymmetry (MTRasym), magnetization transfer ratio normalized by reference signal (MTRnormref), and spillover-corrected magnetization transfer ratio yielding Rex (MTRRex), and metrics based on Lorentzian fitting (Fit-amide, Fit-MTRnormref, and Fit-MTRRex) were calculated. Group differences were compared between IDH genotypes, and among three glioma subtypes. The diagnostic performances were assessed using the receiver operating characteristic (ROC) analysis and compared. The correlations with Ki-67 expression were also analyzed.
RESULTS: All APTw-related metrics exhibited significantly higher values in IDH-wildtype gliomas than in IDH-mutant gliomas (all p < 0.001). Fit-MTRnormref had the best area under the curve (AUC) of 0.858. All APTw-related metrics in glioblastomas were significantly higher than oligodendrogliomas (all p < 0.01) and astrocytomas (all p < 0.001). No metrics had significant difference between oligodendrogliomas and astrocytomas. The highest AUCs was 0.870 for Fit-MTRnormref in distinguishing astrocytomas from glioblastomas, and 0.867 for Fit-MTRRex in distinguishing oligodendrogliomas from glioblastomas. Besides, Fit-MTRnormref had the highest correlation coefficient with Ki-67 expression of 0.578.
CONCLUSION: APTw-related metrics can effectively evaluate glioma IDH status, tumor subtypes and proliferation. The combination of Lorentzian fitting and the reference signal normalization could further improve the diagnostic performance, and perform better than MTRasym.
引用
- Zhu H, Liu Y, Li Y, et al. Amide Proton Transfer-weighted (APTw) Imaging and Derived Quantitative Metrics in Evaluating Gliomas: Improved Performance Compared to Magnetization Transfer Ratio Asymmetry (MTRasym). Acad Radiol. 2025. PMID: 39809602. doi:10.1016/j.acra.2024.12.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。